GBSciences

Curated by Signal

Developer of cannabinoid therapeutics for cardiovascular and other conditions

Overview

Developer of cannabinoid therapeutics for cardiovascular and other conditions. The pipeline includes neurodegenerative disease-targeting formulations and proprietary formulas designed to treat inflammatory disorders, heart disorders, and chronic pain.

Key facts

Founded: 1967
Headquarters: Las Vegas, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

6 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

AION Prosthetics
Developer of prosthetic hands
Life Sciences TechnologyLincoln, United States
Finch Therapeutics
Developer of microbiome-based therapies by using human-first discovery platform
Life Sciences TechnologySomerville, United States
Avlimil
Manufactures natural ingredients based menopause supplement
Life Sciences TechnologyCincinnati, United States

About GBSciences

What does GBSciences do?

Developer of cannabinoid therapeutics for cardiovascular and other conditions.

Where is GBSciences headquartered?

GBSciences is headquartered in Las Vegas, United States.

When was GBSciences founded?

GBSciences was founded in 1967.

Which sector is GBSciences in?

GBSciences operates in Life Sciences Technology.

Who are GBSciences's competitors?

Companies similar to GBSciences include AION Prosthetics, Finch Therapeutics, and Avlimil.